Bristol Myers Squibb Co | OTC Capital Partners
Thursday, February 9, 2012

Skin cancer drug news boosts Bristol shares

Posted by Reuters: Business News on June 7, 2010

NEW YORK/LONDON (Reuters) – Bristol-Myers Squibb Co’s shares rose more than 8 percent on Monday after news over the weekend that its experimental drug ipilimumab extended survival in patients with deadly skin cancer.



Source >>>

Comments: Comments are off for this article

Filed Under: Reuters Business News

Tags: , , , , , , , , , , , , , ,

Bristol sets baseline for profits post-Plavix

Posted by Reuters: Business News on March 4, 2010

NEW YORK (Reuters) – Bristol-Myers Squibb Co set a baseline for profits in 2013 as it provided investors their first glimpse of life after Plavix, the world’s second-bestselling drug.



Source >>>

Comments: Comments are off for this article

Filed Under: Reuters Business News

Tags: , , , , , , , , ,

home top